Reference ranges for ambulatory heart rate measurements in a middle-aged population
- PMID: 38580434
- PMCID: PMC11137473
- DOI: 10.1136/heartjnl-2023-323681
Reference ranges for ambulatory heart rate measurements in a middle-aged population
Abstract
Background: Elevated heart rate (HR) predicts cardiovascular disease and mortality, but there are no established normal limits for ambulatory HR. We used data from the Swedish CArdioPulmonary Imaging Study to determine reference ranges for ambulatory HR in a middle-aged population. We also studied clinical correlates of ambulatory HR.
Methods: A 24-hour ECG was registered in 5809 atrial fibrillation-free individuals, aged 50-65 years. A healthy subset (n=3942) was used to establish reference values (excluding persons with beta-blockers, cardiovascular disease, hypertension, heart failure, anaemia, diabetes, sleep apnoea or chronic obstructive pulmonary disease).Minimum HR was defined as the lowest 1-minute HR. Reference ranges are reported as means±SDs and 2.5th-97.5th percentiles. Clinical correlates of ambulatory HR were analysed with multivariable linear regression.
Results: The average mean and minimum HRs were 73±9 and 48±7 beats per minute (bpm) in men and 76±8 and 51±7 bpm in women; the reference range for mean ambulatory HR was 57-90 bpm in men and 61-92 bpm in women. Average daytime and night-time HRs are also reported. Clinical correlates, including age, sex, height, body mass index, physical activity, smoking, alcohol intake, diabetes, hypertension, haemoglobin level, use of beta-blockers, estimated glomerular filtration rate, per cent of predicted forced expiratory volume in 1 s and coronary artery calcium score, explained <15% of the interindividual differences in HR.
Conclusion: Ambulatory HR varies widely in healthy middle-aged individuals, a finding with relevance for the management of patients with a perception of tachycardia. Differences in ambulatory HR between individuals are largely independent of common clinical correlates.
Keywords: Bradycardia; Electrocardiography; Epidemiology.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: AF has received speaker fees from Bristol-Myers Squibb, Finapres Medical Systems and Medtronic, and is a consultant to Argenx and Medtronic in the field of syncope, cardiovascular autonomic dysfunction and postural orthostatic tachycardia syndrome. LSBJ receives consulting fees from MEDICALgorithmics. JS is a shareholder of Symptoms Europe and Anagram kommunikation. JSH has research grants and speaker fees from BMS/Pfizer, Boehringer-Ingelheim, Boston Scientific, Novartis, Medtronic and Servier.
Figures
References
MeSH terms
LinkOut - more resources
Full Text Sources